These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 6601511

  • 1. The use of cellular immunoadsorbents to prepare polyclonal antibodies that distinguish between antigens derived from human melanoma cells and autologous lymphocytes.
    Kelleher PJ, Mathews HL, Moore GE, Minden P.
    Cancer Immunol Immunother; 1983; 14(3):191-5. PubMed ID: 6601511
    [Abstract] [Full Text] [Related]

  • 2. The use of cellular immunoadsorbents to prepare antibody that distinguishes between syngeneic surface antigens on two guinea pig hepatocarcinomas.
    Mathews HL, Brunda MJ, Minden P.
    J Immunol; 1980 Mar; 124(3):1141-7. PubMed ID: 7358979
    [Abstract] [Full Text] [Related]

  • 3. A glycoprotein of molecular weight 85,000 on human cells of B-lineage: detection with a family of monoclonal antibodies.
    Letarte M, Iturbe S, Quackenbush EJ.
    Mol Immunol; 1985 Feb; 22(2):113-24. PubMed ID: 2579328
    [Abstract] [Full Text] [Related]

  • 4. Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.
    Real FX, Mattes MJ, Houghton AN, Oettgen HF, Lloyd KO, Old LJ.
    J Exp Med; 1984 Oct 01; 160(4):1219-33. PubMed ID: 6237165
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Production and characterization of xenogeneic antisera to tumor-associated antigen(s).
    Gupta RK, Silver HK, Morton DL.
    J Surg Oncol; 1980 Oct 01; 13(1):75-89. PubMed ID: 6153230
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL, Rivoltini L, Mancini M, Ng J, Hartzman RJ, Rosenberg SA.
    Int J Cancer; 1994 Jul 01; 58(1):69-79. PubMed ID: 7516926
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
    Saxton RE, Mann BD, Morton DL, Burk MW.
    Hybridoma; 1982 Jul 01; 1(4):433-45. PubMed ID: 6208138
    [Abstract] [Full Text] [Related]

  • 11. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
    Quackenbush EJ, Letarte M.
    J Immunol; 1985 Feb 01; 134(2):1276-85. PubMed ID: 3155538
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative study of the binding characteristics of monoclonal antimelanoma antibodies.
    Herlyn M, Steplewski Z, Atkinson BF, Ernst CS, Koprowski H.
    Hybridoma; 1982 Feb 01; 1(4):403-11. PubMed ID: 6765323
    [Abstract] [Full Text] [Related]

  • 14. Characterization of a novel neuroglandular antigen (NGA) expressed on abnormal human melanocytes.
    Sikora LK, Pinto A, Demetrick DJ, Dixon WT, Urbanski SJ, Temple W, Jerry LM.
    Int J Cancer; 1987 Feb 15; 39(2):138-45. PubMed ID: 3804488
    [Abstract] [Full Text] [Related]

  • 15. A solid-phase radioimmunoassay to detect antibodies produced by hybridomas to antigens derived from human melanoma cells.
    Kelleher PJ, Mathews HL, Woods LK, Farr RS, Minden P.
    Cancer Immunol Immunother; 1983 Feb 15; 14(3):185-90. PubMed ID: 6551193
    [Abstract] [Full Text] [Related]

  • 16. Isolation and partial characterization of melanoma-associated antigens identified by autologous antibody.
    Vlock DR, Scalise D, Meglin N, Kirkwood JM, Ballou B.
    J Clin Invest; 1988 Jun 15; 81(6):1746-51. PubMed ID: 3384949
    [Abstract] [Full Text] [Related]

  • 17. Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies.
    Chen YT, Stockert E, Chen Y, Garin-Chesa P, Rettig WJ, van der Bruggen P, Boon T, Old LJ.
    Proc Natl Acad Sci U S A; 1994 Feb 01; 91(3):1004-8. PubMed ID: 8302824
    [Abstract] [Full Text] [Related]

  • 18. Demonstration of a well-characterized tumor-associated antigen on melanoma cell surface.
    Wong JH, Gupta RK, Morton DL.
    J Surg Oncol; 1988 Jul 01; 38(3):147-50. PubMed ID: 3292843
    [Abstract] [Full Text] [Related]

  • 19. The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines.
    Livingston PO, Kaelin K, Pinsky CM, Oettgen HF, Old LJ.
    Cancer; 1985 Nov 01; 56(9):2194-200. PubMed ID: 4052966
    [Abstract] [Full Text] [Related]

  • 20. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera.
    Schneider MU, Troye M, Paulie S, Perlmann P.
    Int J Cancer; 1980 Aug 01; 26(2):185-92. PubMed ID: 7203712
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.